In today's world, 6-Fluoronorepinephrine has become a topic of great relevance and interest to a wide spectrum of people. In recent years, interest in 6-Fluoronorepinephrine has been increasing, generating a debate around its implications and repercussions in various areas. From the political to the cultural sphere, 6-Fluoronorepinephrine has aroused the interest of academics, activists, politicians and ordinary citizens. In this article, we will explore the different facets of 6-Fluoronorepinephrine, analyzing its impact, its evolution, and possible solutions to address the challenges it poses.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C8H10FNO3 |
Molar mass | 187.170 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
6-Fluoronorepinephrine (6-FNE) is a selective α1- and α2-adrenergic receptor full agonist related to norepinephrine.[1][2] It is the only selective full agonist for the α-adrenergic receptors known to date and has been used to study their function in scientific research.[2] Infusion of 6-FNE into the locus coeruleus of rodents produces marked hyperactivity and behavioral disinhibition by suppressing activity in the area via stimulation of α1-adrenergic receptors.[2][3]
Phenethylamines |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphetamines |
| ||||||||||||||||
Phentermines |
| ||||||||||||||||
Cathinones |
| ||||||||||||||||
Phenylisobutylamines (and further-extended) | |||||||||||||||||
Catecholamines (and close relatives) |
| ||||||||||||||||
Cyclized phenethylamines |
| ||||||||||||||||
Related compounds |
| ||||||||||||||||